commercial unit manager
Al mojil drug company
Total des années d'expérience :18 years, 2 Mois
Driving commercial & business excellence,
building & leading teams, cross-functional initiatives & promotional activities to increase top and bottom line results via optimized resources allocation .
Wholesale pharmaceuticals Sales Management.
Responsible for managing commercial operation in private market- Kuwait .
Distributor of world class brands in partnership with global & regional pharmaceutical companies.
Reporting to Division Director.
Managing team of 9 (6 Sales Reps & 2 biomedical Eng. &1 App. Specialist).
Distributor for some of global admired medical & Pharma organizations
E.g. Fresenius Medical Care® (Renal Dialysis Business & Fresenius Kabi®).
Achieved sales growth 2019, 2018 &2017 by 118%, 102%& 122% respectively.
Managed negotiations& awarded new Mowasat H Renal dialysis unit tender.
Managed negotiations& awarded IDH& Adan dialysis units Subcontracts 2019.
Managed to pass two FMC Audits for Technical & Pharmacovigilance.
Supervise day to day operation of dialysis unit at Ministry of defense Hospital.
Manage inventory & demand planning of the needed equipment &disposals.
Supervise technical team to ensure smooth operation.
Reporting to General Manager.
Managing team of 3 (2 product specialist & 1 biomedical engineer)
B Braun® Wound Care, Urinary Care & Stoma Care.
Mentor® J&J company, Breast Augmentation & Byron Liposuction
Acclarent® J&J Company, Balloon Sinuplasty - Eustachian Tube balloon
Pharmascience® Canadian Generic Pharmaceutical manufacturer.
Janssen Pharmaceutical Companies of J&J GCC, Kuwait-Office
Company recognition gift for “extra-ordinary performance” for Simponi®
Product Launch & Drug enlisting as a stock item within three months.
Achieved sales plan 2014 by 99% & growth -29%
Achieved sales plan 2013 by 101% & growth 16%
Achieved sales plan 2012 by 133% & growth 50%
Executed educational project for GPs with co-operation of MOH- Kuwait
Training Champion Assignment (manager of Team developmental plan)
Developing Remicade® business in MOH, Institutions & private Sector
Achieved Remicade® sales plan 2010 by 101% & year 2011 by 100%
Executed Referral Program (remote Area Eastern Zone - KSA )
Achieved Peg-Intron® plan 2009 by 103% .
Executed out Reach Program hepatology for none hepatologiest
Successfully Executed Planned Launch activities in Jeddah
Drug Enlisted in Fakeeh H & National Guard H (2008 Achievement 136%)
Attended IBSA ‘s
Achieved 110% private sales year 2006 & 36% growth in sales
Achieved A2A1 against Novartis matrix for sales and MKT Share growth
Ranked No Three among CVS1 team, Egypt for year 2006
Le lien a été supprimé pour non-respect des conditions d'utilisation. Veuillez contacter l’équipe d'assistance pour plus d'informations.